Works matching IS 1742464X AND DT 2022 AND VI 289 AND IP 5
Results: 14
Cancer epigenetics: promises and pitfalls for cancer therapy.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1156, doi. 10.1111/febs.16395
- By:
- Publication type:
- Article
EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1329, doi. 10.1111/febs.16334
- By:
- Publication type:
- Article
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1302, doi. 10.1111/febs.16032
- Publication type:
- Article
Epithelial‐to‐mesenchymal‐like transition events in melanoma.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1352, doi. 10.1111/febs.16021
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1369, doi. 10.1111/febs.15976
- Publication type:
- Article
Issue Information.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1153, doi. 10.1111/febs.15975
- Publication type:
- Article
Therapeutic targeting of chromatin: status and opportunities.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1276, doi. 10.1111/febs.15966
- By:
- Publication type:
- Article
Oncohistones: a roadmap to stalled development.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1315, doi. 10.1111/febs.15963
- By:
- Publication type:
- Article
The duality of PRDM proteins: epigenetic and structural perspectives.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1256, doi. 10.1111/febs.15844
- By:
- Publication type:
- Article
Physical mechanisms of chromatin spatial organization.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1180, doi. 10.1111/febs.15762
- By:
- Publication type:
- Article
Clinical advances in targeting epigenetics for cancer therapy.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1214, doi. 10.1111/febs.15750
- By:
- Publication type:
- Article
The transcriptional regulation of normal and malignant blood cell development.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1240, doi. 10.1111/febs.15735
- By:
- Publication type:
- Article
Transposable element regulation and expression in cancer.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1160, doi. 10.1111/febs.15722
- By:
- Publication type:
- Article
Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challenges.
- Published in:
- FEBS Journal, 2022, v. 289, n. 5, p. 1191, doi. 10.1111/febs.15707
- By:
- Publication type:
- Article